These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30590615)

  • 21. Friedreich ataxia: an update on animal models, frataxin function and therapies.
    González-Cabo P; Llorens JV; Palau F; Moltó MD
    Adv Exp Med Biol; 2009; 652():247-61. PubMed ID: 20225031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function.
    Selak MA; Lyver E; Micklow E; Deutsch EC; Onder O; Selamoglu N; Yager C; Knight S; Carroll M; Daldal F; Dancis A; Lynch DR; Sarry JE
    Mitochondrion; 2011 Mar; 11(2):342-50. PubMed ID: 21147271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.
    Lodi R; Cooper JM; Bradley JL; Manners D; Styles P; Taylor DJ; Schapira AH
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11492-5. PubMed ID: 10500204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Friedreich ataxia: a paradigm for mitochondrial diseases.
    Puccio H; Koenig M
    Curr Opin Genet Dev; 2002 Jun; 12(3):272-7. PubMed ID: 12076669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Mitochondrial and Cytosolic FXN Isoform Expression on Mitochondrial Dynamics and Metabolism.
    Agrò M; Díaz-Nido J
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vivo mitochondrial two-step maturation of human frataxin.
    Schmucker S; Argentini M; Carelle-Calmels N; Martelli A; Puccio H
    Hum Mol Genet; 2008 Nov; 17(22):3521-31. PubMed ID: 18725397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron metabolism and mitochondrial abnormalities in Friedreich ataxia.
    Pandolfo M
    Blood Cells Mol Dis; 2002; 29(3):536-47; discussion 548-52. PubMed ID: 12547248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia.
    Vaubel RA; Isaya G
    Mol Cell Neurosci; 2013 Jul; 55():50-61. PubMed ID: 22917739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae.
    Cavadini P; Gellera C; Patel PI; Isaya G
    Hum Mol Genet; 2000 Oct; 9(17):2523-30. PubMed ID: 11030757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.
    Rötig A; de Lonlay P; Chretien D; Foury F; Koenig M; Sidi D; Munnich A; Rustin P
    Nat Genet; 1997 Oct; 17(2):215-7. PubMed ID: 9326946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of Drosophila frataxin triggers cell death in an iron-dependent manner.
    Edenharter O; Clement J; Schneuwly S; Navarro JA
    J Neurogenet; 2017 Dec; 31(4):189-202. PubMed ID: 28838288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia.
    Rufini A; Fortuni S; Arcuri G; Condò I; Serio D; Incani O; Malisan F; Ventura N; Testi R
    Hum Mol Genet; 2011 Apr; 20(7):1253-61. PubMed ID: 21216878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
    Gomes CM; Santos R
    Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of Mitochondrial Iron-Sulfur Protein Biogenesis.
    Lill R; Freibert SA
    Annu Rev Biochem; 2020 Jun; 89():471-499. PubMed ID: 31935115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts.
    Kemp K; Mallam E; Hares K; Witherick J; Scolding N; Wilkins A
    PLoS One; 2011; 6(10):e26098. PubMed ID: 22016819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia.
    Soriano S; Llorens JV; Blanco-Sobero L; Gutiérrez L; Calap-Quintana P; Morales MP; Moltó MD; Martínez-Sebastián MJ
    Gene; 2013 Jun; 521(2):274-81. PubMed ID: 23542074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
    Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
    J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia.
    Cotticelli MG; Xia S; Lin D; Lee T; Terrab L; Wipf P; Huryn DM; Wilson RB
    J Pharmacol Exp Ther; 2019 Apr; 369(1):47-54. PubMed ID: 30635474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts.
    Khonsari H; Schneider M; Al-Mahdawi S; Chianea YG; Themis M; Parris C; Pook MA; Themis M
    Gene Ther; 2016 Dec; 23(12):846-856. PubMed ID: 27518705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No changes in heme synthesis in human Friedreich´s ataxia erythroid progenitor cells.
    Steinkellner H; Singh HN; Muckenthaler MU; Goldenberg H; Moganty RR; Scheiber-Mojdehkar B; Sturm B
    Gene; 2017 Jul; 621():5-11. PubMed ID: 28412459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.